HIV Funding Impacts Global health funding · LMIC Download the panel

Home  /  South Asia  /  PAK

Pakistan

Pakistan appears only through international and donor bodies that compile figures across many countries, and no figures for the country are read directly from a national publisher. The assessment of national sources, country by country, is set out on the Methods page.

340,000
People living with HIV, 2025
WHO Global Health Observatory
18.0%
On antiretroviral treatment, 2025
WHO Global Health Observatory
$1.5m
United States HIV disbursements, 2023
OECD Creditor Reporting System
$25.1m
External HIV financing, all donors, 2024
OECD Creditor Reporting System
External HIV financing
OECD CRS · ForeignAssistance.gov
$-10m$0$10m$20m$30m20022005200820112014201720202023$25.1m$1.5m$24.2m$1.5m
  • All donors
  • United States, OECD record
  • The Global Fund
  • United States, self-reported
YearAll donorsUnited States, OECD recordThe Global FundUnited States, self-reported
2002 $589k — — —
2003 $2.1m — $568k —
2004 $8.1m $1.2m $1.6m $958k
2005 $8.1m $900k $255k $1.3m
2006 $14.2m $76k $3.3m $96k
2007 $17.8m $4.1m $1.3m $4.1m
2008 $12.7m $1.2m $313k $939k
2009 $8.5m $2.5m $390k $2.7m
2010 $4.4m $898k — $548k
2011 $15.4m $8.5m $2.8m $813k
2012 $5.8m $306k $3.5m $8.4m
2013 $4.7m $616k $1.6m $547k
2014 $8.1m $319k $3.1m $404k
2015 $19.3m $2.5m $9.0m $-109k
2016 $10.7m $32k $5.6m $308k
2017 $13.5m — $10.1m —
2018 $9.2m $12k $8.0m $8k
2019 $14.1m $13k $12.0m $17k
2020 $15.2m — $12.0m —
2021 $21.9m — $16.7m —
2022 $17.2m $7k $16.3m $7k
2023 $35.4m $1.5m $32.5m $1.5m
2024 $25.1m — $24.2m —

23 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Disbursements reported for the country. The OECD record and the United States self-reported record are drawn separately. The two records cover the same United States disbursements, but the OECD record is filed by calendar year and the self-reported record by United States fiscal year.

People living with HIV and people on treatment
UNAIDS AIDSinfo
0200k400k200020032006200920122015201820212024350,00056,000
  • People living with HIV
  • People on treatment
YearPeople living with HIVPeople living with HIV (lower)People living with HIV (upper)People on treatment
2000 630 550 700 —
2001 810 710 910 —
2002 1,100 950 1,200 —
2003 2,100 1,800 2,300 —
2004 7,900 6,900 8,900 —
2005 18,000 15,000 20,000 —
2006 28,000 24,000 32,000 —
2007 41,000 34,000 46,000 —
2008 54,000 46,000 62,000 —
2009 68,000 58,000 77,000 —
2010 81,000 70,000 91,000 1,900
2011 94,000 81,000 100,000 2,000
2012 110,000 93,000 120,000 3,100
2013 120,000 110,000 130,000 3,400
2014 130,000 120,000 150,000 5,000
2015 150,000 130,000 160,000 6,600
2016 160,000 140,000 180,000 8,900
2017 180,000 160,000 190,000 12,000
2018 200,000 170,000 210,000 16,000
2019 220,000 190,000 230,000 23,000
2020 240,000 210,000 260,000 24,000
2021 260,000 240,000 280,000 27,000
2022 290,000 260,000 300,000 34,000
2023 310,000 290,000 340,000 45,000
2024 350,000 320,000 370,000 56,000

25 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Modelled estimates. The shaded area is the published uncertainty interval around the number of people living with HIV, because a single estimate without the interval would overstate the precision of the model.

The treatment cascade
UNAIDS AIDSinfo
0%10%20%2010201220142016201820202022202421.0%16.0%
  • Diagnosed
  • On treatment
YearDiagnosedOn treatment
2010 — 2.0%
2011 — 2.0%
2012 — 3.0%
2013 — 3.0%
2014 8.0% 4.0%
2015 10.0% 4.0%
2016 11.0% 5.0%
2017 13.0% 7.0%
2018 15.0% 8.0%
2019 18.0% 11.0%
2020 19.0% 10.0%
2021 19.0% 10.0%
2022 19.0% 12.0%
2023 21.0% 14.0%
2024 21.0% 16.0%

15 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Every line is a percentage of all people living with HIV, so the three lines share a denominator and can be compared directly. Viral suppression in the figure is the share of all people living with HIV who are virally suppressed, and not the narrower third 95 target, which counts only people on treatment.

Sources of the figures for Pakistan

2,685 rows

SourceTypeRowsIndicators YearsRead fromRetrieved
UNICEF HIV/AIDS dataset Modelled estimate 1,376 5 2010–2025 sdmx.data.unicef.org 2026-10-20
UNAIDS AIDSinfo Modelled estimate 601 24 2000–2024 aidsinfo.unaids.org 2026-10-20
WHO Global Health Observatory Modelled estimate 237 12 2000–2025 ghoapi.azureedge.net 2026-10-12
WHO Global Tuberculosis Programme Programme record 163 17 2000–2025 extranet.who.int 2026-10-16
Global Fund Data Service Programme record 65 12 2017–2025 fetch.theglobalfund.org 2026-10-12
IATI, through d-portal Expenditure account 62 3 2000–2026 d-portal.org 2026-10-12
OECD Creditor Reporting System Expenditure account 61 3 2002–2024 sdmx.oecd.org 2026-10-12
World Bank Open Data Modelled estimate 51 2 2000–2025 api.worldbank.org 2026-10-12
ForeignAssistance.gov Expenditure account 34 2 2004–2023 foreignassistance.gov 2026-10-29
UNAIDS Global AIDS Monitoring expenditure database Expenditure account 16 11 2019–2022 hivfinancial.unaids.org 2026-10-12
WHO HIV testing services dashboard Programme record 10 4 2018–2022 eic-database-290813.ew.r.appspot.com 2026-10-14
UNAIDS Data 2025 country databook Expenditure account 5 3 2019–2022 aidsinfo.unaids.org 2026-10-15
Global Fund allocations Expenditure account 4 1 2017–2026 fetch.theglobalfund.org 2026-10-12

Indicators held

66 of 150

IndicatorDomainUnitRows YearsSourcesMost recent value
Actual expenditure on collaborative TB/HIV activities Financing USD 8 2017–2024 WHO Global Tuberculosis Programme $63k (2024)
Budget required for collaborative TB/HIV activities Financing USD 8 2018–2025 WHO Global Tuberculosis Programme $251k (2025)
Country-reported HIV expenditure, all sources Financing USD 6 2012–2022 UNAIDS AIDSinfo, UNAIDS Global AIDS Monitoring expenditure database $20.5m (2022)
Domestic funding received by the national TB programme Financing USD 8 2017–2024 WHO Global Tuberculosis Programme $0 (2024)
Domestic public HIV expenditure Financing USD 4 2019–2022 UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database $9.7m (2022)
Expected Global Fund funding for the national TB programme Financing USD 8 2018–2025 WHO Global Tuberculosis Programme $55.5m (2025)
Expected USAID funding for the national TB programme Financing USD 7 2018–2025 WHO Global Tuberculosis Programme $0 (2025)
Expected domestic funding for the national TB programme Financing USD 8 2018–2025 WHO Global Tuberculosis Programme $0 (2025)
Expected funding for collaborative TB/HIV activities Financing USD 8 2018–2025 WHO Global Tuberculosis Programme $251k (2025)
External HIV financing (all donors, ODA) Financing USD 23 2002–2024 OECD Creditor Reporting System $25.1m (2024)
External HIV financing from governments other than the United States (IATI) Financing USD 26 2000–2025 IATI, through d-portal $136k (2025)
External HIV financing from multilateral bodies other than the Global Fund (IATI) Financing USD 13 2014–2026 IATI, through d-portal $102k (2026)
External HIV financing from the United States (ODA) Financing USD 34 2004–2023 ForeignAssistance.gov, OECD Creditor Reporting System $1.5m (2023)
Funding received for collaborative TB/HIV activities Financing USD 8 2017–2024 WHO Global Tuberculosis Programme $70k (2024)
Global Fund HIV allocation for a whole three-year cycle, not an annual figure Financing USD per three-year allocation cycle 4 2017–2026 Global Fund allocations 52,632,801 (2026)
Global Fund HIV disbursements to the country Financing USD 46 2003–2026 IATI, through d-portal, OECD Creditor Reporting System, UNAIDS Global AIDS Monitoring expenditure database $10.2m (2026)
Global Fund funding received by the national TB programme Financing USD 8 2017–2024 WHO Global Tuberculosis Programme $46.2m (2024)
HIV spending on TB/HIV co-infection Financing USD 1 2022 UNAIDS Global AIDS Monitoring expenditure database $71k (2022)
HIV spending on prevention Financing USD 1 2022 UNAIDS Global AIDS Monitoring expenditure database $2.9m (2022)
HIV spending on prevention of vertical transmission Financing USD 1 2019 UNAIDS Global AIDS Monitoring expenditure database $1.6m (2019)
HIV spending on treatment, care and support Financing USD 2 2019–2022 UNAIDS Global AIDS Monitoring expenditure database $13.5m (2022)
International HIV expenditure (country-reported) Financing USD 4 2019–2022 UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database $10.8m (2022)
Other bilateral HIV expenditure (country-reported) Financing USD 1 2019 UNAIDS Global AIDS Monitoring expenditure database $8k (2019)
Out-of-pocket HIV expenditure by households Financing USD 1 2019 UNAIDS Global AIDS Monitoring expenditure database $5.6m (2019)
Private HIV expenditure (country-reported) Financing USD 2 2019 UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database $5.6m (2019)
US HIV disbursements managed by USAID Financing USD 17 2004–2023 ForeignAssistance.gov $1.5m (2023)
USAID funding received by the national TB programme Financing USD 7 2017–2024 WHO Global Tuberculosis Programme $0 (2024)
% of ALL PLHIV who are virally suppressed Treatment cascade percent 4 2023–2024 UNAIDS AIDSinfo, WHO Global Health Observatory 7.0% (2024)
% of PLHIV on ART (second 95, PLHIV base) Treatment cascade percent 72 2000–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 18.0% (2025)
% of PLHIV who have been diagnosed (first 95) Treatment cascade percent 26 2014–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 25.0% (2025)
% of estimated HIV-positive incident TB cases on TB treatment and ART Treatment cascade percent 21 2004–2024 UNAIDS AIDSinfo 25.7% (2024)
% of people currently enrolled in HIV treatment started on TB preventive therapy Treatment cascade percent 1 2024 UNAIDS AIDSinfo 13.1% (2024)
% of people newly enrolled in HIV treatment diagnosed with TB disease Treatment cascade percent 4 2021–2024 UNAIDS AIDSinfo 4.0% (2024)
% of people on ART who are virally suppressed (third 95) Treatment cascade percent 2 2023–2024 WHO Global Health Observatory 41.0% (2024)
% of returned HIV test results that were positive Treatment cascade percent 8 2022 UNAIDS AIDSinfo, WHO Global Health Observatory, WHO HIV testing services dashboard 8.7% (2022)
HIV tests performed at a health facility Treatment cascade count 1 2022 WHO HIV testing services dashboard 45,127 (2022)
HIV tests performed through community outreach Treatment cascade count 3 2018–2022 WHO HIV testing services dashboard 103,969 (2022)
HIV tests performed with the result returned to the person Treatment cascade count 8 2022 UNAIDS AIDSinfo, WHO Global Health Observatory, WHO HIV testing services dashboard 149,096 (2022)
HIV-exposed infants tested within two months of birth Treatment cascade percent 13 2010–2024 UNAIDS AIDSinfo 20.0% (2024)
HIV-positive TB patients started or continued on ART Treatment cascade count 15 2015–2025 Global Fund Data Service, WHO Global Tuberculosis Programme 586 (2025)
Key-population people tested for HIV (count over the period) Treatment cascade count 9 2018–2020 Global Fund Data Service By population group, sex or age only, to 2020
Number newly diagnosed HIV-positive (PEPFAR MER HTS_TST_POS) Treatment cascade count 1 2024 Global Fund Data Service 788 (2024)
Number of people on ART (PEPFAR MER TX_CURR) Treatment cascade count 77 2000–2025 Global Fund Data Service, UNAIDS AIDSinfo, WHO Global Health Observatory, WHO Global Tuberculosis Programme 60,753 (2025)
PMTCT ART coverage among pregnant women with HIV Treatment cascade percent 31 2010–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset 22.0% (2025)
People living with HIV in care screened for TB Treatment cascade count 5 2017–2025 Global Fund Data Service 12,286 (2025)
People living with HIV on ART who started TB preventive therapy Treatment cascade count 5 2021–2025 Global Fund Data Service 3,701 (2025)
People newly enrolled on ART during the year Treatment cascade count 8 2021–2024 Global Fund Data Service, WHO Global Tuberculosis Programme 13,001 (2024)
People who completed a course of TB preventive therapy Treatment cascade count 2 2024–2025 Global Fund Data Service 22,836 (2025)
Pregnant women with HIV who received ARVs for PMTCT Treatment cascade count 35 2010–2025 Global Fund Data Service, UNAIDS AIDSinfo, WHO Global Health Observatory 833 (2025)
TB patients recorded as HIV-positive Treatment cascade count 10 2015–2024 WHO Global Tuberculosis Programme 953 (2024)
TB patients with an HIV test result recorded Treatment cascade count 19 2015–2025 Global Fund Data Service, WHO Global Tuberculosis Programme 279,009 (2025)
AIDS-related deaths Epidemic estimates count 681 2000–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory 14,000 (2025)
Deaths from TB among people living with HIV Epidemic estimates count 50 2000–2024 UNAIDS AIDSinfo, WHO Global Tuberculosis Programme 690 (2024)
HIV prevalence among a key population Epidemic estimates percent 5 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
HIV prevalence, ages 15-49 Epidemic estimates percent 50 2000–2024 UNAIDS AIDSinfo, World Bank Open Data 0.2% (2024)
Incident TB cases among people living with HIV Epidemic estimates count 50 2000–2024 UNAIDS AIDSinfo, WHO Global Tuberculosis Programme 2,600 (2024)
New HIV infections Epidemic estimates count 410 2000–2025 UNICEF HIV/AIDS dataset, WHO Global Health Observatory 44,000 (2025)
People living with HIV Epidemic estimates count 681 2000–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory 340,000 (2025)
Key-population members reached by prevention programmes Prevention and outreach percent 4 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
Key-population people reached by outreach (count over the period) Prevention and outreach count 9 2018–2020 Global Fund Data Service By population group, sex or age only, to 2020
Male condoms distributed in a year Prevention and outreach count 5 2019–2024 UNAIDS AIDSinfo 19,208,787 (2024)
People receiving PrEP Prevention and outreach count 3 2022–2024 Global Fund Data Service By population group, sex or age only, to 2024
Estimated pregnant women with HIV needing ARVs for PMTCT Population denominators count 31 2010–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 3,800 (2025)
Estimated size of a key population Population denominators count 5 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
Total population Population denominators count 26 2000–2025 World Bank Open Data 255,219,554 (2025)
Share of HIV-exposed infants who acquire HIV — percent 31 2010–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset 41.3% (2025)

Every row shown on the Pakistan page is in the panel download, with the source URL and the retrieval date of the row attached. See Data.